Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-07-30, Stock:JNJ, The news for the past five days is as follows:
2021-07-23: NEWS1: Stock Market Rally Rebounds To Highs; Snap, Crocs, Chipotle, Netflix Are Key Earnings.NEWS2: COVID SCIENCE-J&J shot recipients may need a booster; new advice on infected kids.NEWS3: Top Research Reports for Johnson & Johnson, Oracle & SAP.NEWS4: Doctor on the Olympics regarding COVID-19: ‘There are a lot of concerns’.NEWS5: 10 Best Dividend Contenders to Buy in 2021.NEWS6: This is the tipping point for when people vaccinated against COVID-19 should mask up again indoors.NEWS7: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Johnson & Johnson (NYSE:JNJ) Investigation.NEWS8: Pharma Stock Roundup: JNJ, NVS Q2 Earnings, PFE, ABBV, LLY & MRK FDA Updates.NEWS9: The Big Winner With Johnson & Johnson's Recent FDA Approval.NEWS10: Can Today's Vaccines Beat the Delta Variant?.
2021-07-26: NEWS1: Doctor on COVID-19 vaccination: ‘Too little too late, better late than never, if anything it all counts’.NEWS2: Ocugen CEO on vaccine hesitancy in the U.S..NEWS3: JNJ Option Traders Aim to Continue Positive Trend.NEWS4: UPDATE 1-Aspen to start J&J COVID-19 vaccine supplies to South Africa from Monday.NEWS5: Aspen to start supplies of J&J COVID-19 vaccine to South Africa from Monday.
2021-07-27: NEWS1: CDC urges some vaccinated to wear masks again.NEWS2: Dow Jones Falls Below 35,000 on Boeing and Tech Stock Sell-Offs, Delta Variant Worries.NEWS3: ‘There’s a great opportunity that we’ll have another variant’: Doctor.NEWS4: Why Health Care, Not FAANG Stocks, Ones To Watch In CAN SLIM Portfolio.NEWS5: Drug/Biotech Stock Earnings on Jul 28: PFE, GSK, BMY, BMRN & TLRY.NEWS6: Worries About the Delta Variant Could Be Overdone Based on Clues From These Healthcare Giants.
2021-07-28: NEWS1: U.S. FDA agrees to extend J&J COVID-19 vaccine's shelf-life to 6 months.NEWS2: Judge to Consider Blocking J&J from Giving Talc Claims to Unit.NEWS3: REFILE-UPDATE 1-U.S. House panel seeks J&J documents on baby powder bankruptcy plans.NEWS4: Pfizer authorizes $1 billion for oral COVID-19 treatment, CEO says.NEWS5: U.S. House subcommittee asks J&J for info on baby powder bankruptcy plans - letter.NEWS6: Covid-19 vaccine booster shots will become a reality: Doctor.NEWS7: Ripple effects of the CDC indoor mask guidance.NEWS8: WHO Is Currently Not In Favor Of COVID Booster Shots Citing Lack Of Data: CNBC.NEWS9: Mega Caps Could Lead the S&P 500 Higher.NEWS10: Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.NEWS11: Zimbabwe approves J&J COVID-19 vaccine for emergency use.NEWS12: Legal wrangles hold up U.S. vaccine donations to India.NEWS13: UPDATE 1-Guatemala renegotiates Sputnik V contract to receive 8 mln doses, says president.
2021-07-29: NEWS1: UPDATE 4-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant.NEWS2: We must move towards vaccine mandates to get ahead of Covid-19: Doctor.NEWS3: Smart stock investors know to check this telling sign of a company’s health.NEWS4: Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney.NEWS5: Sandy Hook families offered $33 million, J&J vaccine production to resume in Baltimore, AstraZeneca loses money on vaccine.NEWS6: Emergent BioSolutions Stock Higher As COVID-19 Vaccine Production To Resume At Baltimore Plant.NEWS7: Are Johnson & Johnson's Legal Troubles Enough of a Reason to Avoid the Stock?.NEWS8: 3 Dividend Stocks Safe Enough to Bet the Farm On.NEWS9: Wall Street Might Be Missing This Key to Growth at Johnson & Johnson.NEWS10: Pfizer CEO on South Africa vaccine deal: 'They want to see production happening'.NEWS11: REFILE-UPDATE 3-Emergent to resume J&J COVID-19 vaccine production at Baltimore plant.NEWS12: REFILE-J&J contractor plans to resume COVID-19 vaccine production at Baltimore plant - WSJ.NEWS13: UPDATE 1-J&J says U.S. FDA agrees to extend shelf life of its COVID-19 vaccine.

Answer: Rise